Dimensional Fund Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $551M | Buy |
+2,904,886
| New | +$546M | 0.1% | 163 |
|
|
2026
Q1 | – | Sell |
-3,310,831
| Closed | -$609M | – | 3221 |
|
|
2025
Q4 | $609M | Sell |
3,310,831
-92,117
| -3% | -$16.2M | 0.13% | 104 |
|
|
2025
Q3 | $522M | Buy |
3,402,948
+291,091
| +9% | +$44.1M | 0.11% | 129 |
|
|
2025
Q2 | $435M | Buy |
3,111,857
+459,410
| +17% | +$64.4M | 0.1% | 164 |
|
|
2025
Q1 | $390M | Sell |
2,652,447
-8,747
| -0.3% | -$1.27M | 0.1% | 175 |
|
|
2024
Q4 | $349M | Buy |
2,661,194
+318,268
| +14% | +$44.6M | 0.08% | 219 |
|
|
2024
Q3 | $365M | Buy |
2,342,926
+120,631
| +5% | +$19.5M | 0.09% | 199 |
|
|
2024
Q2 | $347M | Sell |
2,222,295
-56,832
| -2% | -$8.55M | 0.09% | 176 |
|
|
2024
Q1 | $309M | Buy |
2,279,127
+293,376
| +15% | +$38.8M | 0.08% | 220 |
|
|
2023
Q4 | $267M | Buy |
1,985,751
+48,101
| +2% | +$6.25M | 0.08% | 250 |
|
|
2023
Q3 | $262M | Buy |
1,937,650
+412,652
| +27% | +$56.4M | 0.09% | 210 |
|
|
2023
Q2 | $218M | Buy |
1,524,998
+274,336
| +22% | +$40.4M | 0.07% | 299 |
|
|
2023
Q1 | $174M | Buy |
1,250,662
+338,978
| +37% | +$45.6M | 0.06% | 393 |
|
|
2022
Q4 | $124K | Buy |
911,684
+44,778
| +5% | +$5.62M | 0.04% | 618 |
|
|
2022
Q3 | $95.1M | Sell |
866,906
-95,847
| -10% | -$12.2M | 0.04% | 727 |
|
|
2022
Q2 | $127M | Sell |
962,753
-109,890
| -10% | -$14.4M | 0.05% | 545 |
|
|
2022
Q1 | $142M | Sell |
1,072,643
-517,567
| -33% | -$62.1M | 0.04% | 578 |
|
|
2021
Q4 | $185M | Sell |
1,590,210
-367,843
| -19% | -$43.3M | 0.06% | 425 |
|
|
2021
Q3 | $235M | Buy |
1,958,053
+233,655
| +14% | +$27.2M | 0.08% | 266 |
|
|
2021
Q2 | $207M | Sell |
1,724,398
-62,335
| -3% | -$6.84M | 0.07% | 329 |
|
|
2021
Q1 | $178M | Buy |
1,786,733
+17,894
| +1% | +$1.8M | 0.06% | 395 |
|
|
2020
Q4 | $177M | Buy |
1,768,839
+74,693
| +4% | +$7.91M | 0.06% | 335 |
|
|
2020
Q3 | $186M | Buy |
1,694,146
+2,598
| +0.2% | +$289K | 0.08% | 232 |
|
|
2020
Q2 | $179M | Buy |
1,691,548
+43,846
| +3% | +$4.53M | 0.08% | 222 |
|
|
2020
Q1 | $147M | Buy |
1,647,702
+100,955
| +7% | +$9.5M | 0.08% | 214 |
|
|
2019
Q4 | $154M | Buy |
1,546,747
+14,061
| +0.9% | +$1.32M | 0.06% | 411 |
|
|
2019
Q3 | $137M | Buy |
1,532,686
+45,518
| +3% | +$3.95M | 0.05% | 447 |
|
|
2019
Q2 | $123M | Buy |
1,487,168
+124,840
| +9% | +$9.79M | 0.05% | 515 |
|
|
2019
Q1 | $110M | Buy |
1,362,328
+23,294
| +2% | +$1.84M | 0.04% | 588 |
|
|
2018
Q4 | $102M | Buy |
1,339,034
+40,446
| +3% | +$3.16M | 0.05% | 535 |
|
|
2018
Q3 | $103M | Sell |
1,298,588
-6,942
| -0.5% | -$525K | 0.04% | 678 |
|
|
2018
Q2 | $91.7M | Sell |
1,305,530
-11,094
| -0.8% | -$798K | 0.04% | 725 |
|
|
2018
Q1 | $92.1M | Buy |
1,316,624
+15,895
| +1% | +$1.1M | 0.04% | 676 |
|
|
2017
Q4 | $90.3M | Buy |
1,300,729
+21,288
| +2% | +$1.44M | 0.04% | 703 |
|
|
2017
Q3 | $86.7M | Buy |
1,279,441
+197,849
| +18% | +$12.5M | 0.04% | 695 |
|
|
2017
Q2 | $73.7M | Buy |
1,081,592
+56,309
| +5% | +$3.68M | 0.03% | 789 |
|
|
2017
Q1 | $63.9M | Buy |
1,025,283
+2,242
| +0.2% | +$131K | 0.03% | 893 |
|
|
2016
Q4 | $55.9M | Buy |
1,023,041
+22,001
| +2% | +$1.25M | 0.03% | 1013 |
|
|
2016
Q3 | $65.8M | Buy |
1,001,040
+27,480
| +3% | +$1.8M | 0.04% | 753 |
|
|
2016
Q2 | $58.8M | Buy |
973,560
+39,827
| +4% | +$2.31M | 0.03% | 804 |
|
|
2016
Q1 | $52.6M | Sell |
933,733
-8,417
| -0.9% | -$506K | 0.03% | 870 |
|
|
2015
Q4 | $64M | Buy |
942,150
+32,716
| +4% | +$2.14M | 0.04% | 639 |
|
|
2015
Q3 | $57.9M | Sell |
909,434
-3,055
| -0.3% | -$201K | 0.04% | 669 |
|
|
2015
Q2 | $58.1M | Buy |
912,489
+8,356
| +0.9% | +$572K | 0.04% | 725 |
|
|
2015
Q1 | $61.9M | Buy |
904,133
+41,630
| +5% | +$2.89M | 0.04% | 646 |
|
|
2014
Q4 | $60.7M | Buy |
862,503
+63,051
| +8% | +$4.51M | 0.04% | 603 |
|
|
2014
Q3 | $57.1M | Buy |
799,452
+46,862
| +6% | +$3.43M | 0.04% | 582 |
|
|
2014
Q2 | $55.9M | Buy |
752,590
+10,641
| +1% | +$769K | 0.04% | 616 |
|
|
2014
Q1 | $48.1M | Buy |
741,949
+43,469
| +6% | +$2.81M | 0.04% | 679 |
|
|
2013
Q4 | $41.5M | Buy |
698,480
+8,237
| +1% | +$447K | 0.03% | 766 |
|
|
2013
Q3 | $35.8M | Buy |
690,243
+23,768
| +4% | +$1.19M | 0.03% | 785 |
|
|
2013
Q2 | $31.5M | Buy |
+666,475
| New | +$33.9M | 0.03% | 821 |
|
Other funds holding AZN
EP
IA
Dimensional Fund Advisors's AZN Position: Q2 2026 in Review
Dimensional Fund Advisors opened a new position in AstraZeneca (AZN) in Q2 2026: 2,904,886 shares worth $551M. The stake represents 0.1% of the portfolio and ranks #163 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in AZN as recently as Q4 2025.
Dimensional Fund Advisors first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $609M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Dimensional Fund Advisors held 2,904,886 shares of AstraZeneca worth $551M as of Q2 2026.
- AstraZeneca was a new Dimensional Fund Advisors position in Q2 2026.
- AstraZeneca made up 0.1% of Dimensional Fund Advisors's portfolio in Q2 2026, its #163 holding.
- Dimensional Fund Advisors first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- Dimensional Fund Advisors's AstraZeneca position peaked at $609M in Q4 2025.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.